Advances in Chalcones with Anticancer Activities

ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)


Volume 9, 3 Issues, 2014


Download PDF Flyer




Recent Patents on Anti-Cancer Drug Discovery

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 86th of 254 in Pharmacology & Pharmacy
  • 91st of 202 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Khurshid Zaman
Bentham Science Publishers
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.863
5 - Year: 2.512

Advances in Chalcones with Anticancer Activities

Author(s): Chandrabose Karthikeyan, Narayana S.H. Narayana Moorthy, Sakthivel Ramasamy, Uma Vanam, Elangovan Manivannan, Devarajan Karunagaran and Piyush Trivedi

Affiliation: School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Airport Bypass Road, Gandhi Nagar, Bhopal, MP, 462036, India.

Abstract

Chalcones are naturally occurring compounds exhibiting broad spectrum biological activities including anticancer activity through multiple mechanisms. Literature on anticancer chalcones highlights the employment of three pronged strategies, namely; structural manipulation of both aryl rings, replacement of aryl rings with heteroaryl scaffolds, molecular hybridization through conjugation with other pharmacologically interesting scaffolds for enhancement of anticancer properties. Methoxy substitutions on both the aryl rings (A and B) of the chalcones, depending upon their positions in the aryl rings appear to influence anticancer and other activities. Similarly, heterocyclic rings either as ring A or B in chalcones, also influence the anticancer activity shown by this class of compounds. Hybrid chalcones formulated by chemically linking chalcones to other prominent anticancer scaffolds such as pyrrol[2,1-c][1,4]benzodiazepines, benzothiazoles, imidazolones have demonstrated synergistic or additive pharmacological activities. The successful application of these three pronged strategies for discovering novel anticancer agents based on chalcone scaffold has resulted in many novel and chemically diverse chalcones with potential therapeutic application for many types of cancer. This review summarizes the concerted efforts expended on the design and development of anticancer chalcones recorded in recent literature and also provides an overview of the patents published in this area between 2007 and 2014 (WO2013022951, WO201201745 & US2012029489).

Keywords: Anticancer, anticancer chalcones, antioxidant, antiproliferative activity, chalcones, patents.

Download Free Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 10
Issue Number: 1
First Page: 97
Last Page: 115
Page Count: 19
DOI: 10.2174/1574892809666140819153902
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science